Preferred Name |
tyrosinemia type I |
|
Synonyms |
fumarylacetoacetate hydrolase deficiency FAH deficiency fumarylacetoacetase deficiency tyrosinemia type I type I tyrosinemia hepatorenal tyrosinemia tyrosinemia, type 1 TYRSN1 tyrosinemia, type I tyrosinemia type 1 Fah deficiency |
|
Definitions |
Tyrosinemia type 1 (HTI) is an inborn error of tyrosine catabolism caused by defective activity of fumarylacetoacetate hydrolase (FAH) and is characterized by progressive liver disease, renal tubular dysfunction, porphyria-like crises and a dramatic improvement in prognosis following treatment with nitisinone. |
|
ID |
http://purl.obolibrary.org/obo/MONDO_0010161 |
|
has_exact_synonym |
fumarylacetoacetate hydrolase deficiency FAH deficiency fumarylacetoacetase deficiency tyrosinemia type I type I tyrosinemia hepatorenal tyrosinemia |
|
has_related_synonym |
tyrosinemia, type 1 TYRSN1 tyrosinemia, type I tyrosinemia type 1 Fah deficiency |
|
IAO_0000233 | ||
label |
tyrosinemia type I |
|
prefixIRI |
MONDO:0010161 |
|
prefLabel |
tyrosinemia type I |
|
seeAlso |
https://rarediseases.info.nih.gov/diseases/2658/tyrosinemia-type-1 |
|
textual definition |
Tyrosinemia type 1 (HTI) is an inborn error of tyrosine catabolism caused by defective activity of fumarylacetoacetate hydrolase (FAH) and is characterized by progressive liver disease, renal tubular dysfunction, porphyria-like crises and a dramatic improvement in prognosis following treatment with nitisinone. |
|
subClassOf |
http://purl.obolibrary.org/obo/MONDO_0004741 http://purl.obolibrary.org/obo/MONDO_0100191 |